HMGCR and ischemic stroke: The effect of Simvastatin, member of the statin-family and an HMG-CoA reductase inhibitor, in the acute phase of ischemic stroke was investigated in two RCTs; MISTIC [148] (safety and efficacy pilot trial) and STARS [149].